To evaluate effect of Cutisora Oil and Cutisora Tablet in patients of Psoriasis.

A Randomized open labelled,parallel group study to evaluate the safety and efficacy of Cutisora oil and tablet in fixed dose as well as in combination therapy in patients with mild to moderate psoriasis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009908

Enrollment

Registered

2017-09-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Suffering from mild to moderate psoriasis

Interventions

Intervention1: Cutisora oil: ngredients- Azadirachta indica oil,Pongamia pinnata oil,Curcuma longa oil,Piper nigrum oleoresin Mode of administration- external application over lesion Dose- 2 times a

Eligibility

Inclusion criteria

Inclusion criteria: Mild to moderate psoriasis Psoriasis area and severity index of less than 20 Clinical chemistry and hematology results from visit 1 are within normal limits. Non pregnant female and must agree to use adequate method of contraception during the study.

Exclusion criteria

Exclusion criteria: Age less than 18 years and not more than 60 years Evidence of alcohol or drug abuse Evidence of unstable forms of psoriasis, including guttate, erthrodermic, exfoliative or pustular psoriasis. Psoriasis area and severity index of more than 20 patients suffering from any critical disease of vital organs and chronic diseases like cancer, AIDS,TB etc.

Design outcomes

Primary

Measure	Time frame
Change in the psoriasis area and severity index between baseline and end of studyTimepoint: Change in the psoriasis area and severity index between baseline and end of study	—

Secondary

Measure	Time frame
Psoriasis disability index (PDI) at base line and end of studyTimepoint: Time frame at 0 week, 6 week and 12 week	—

Countries

India

Contacts

Public ContactDr Rajesh Sood

Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, Paprola

drrajeshsood@gmail.com9418102424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026